Evidence map›Paper›PMID 24246825›Full record

Trial reportOphthalmology2013

The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study.

Writing Committee for the Cornea Donor Study Research Group, Mark J Mannis, Edward J Holland, Robin L Gal, Mariya Dontchev, Craig Kollman, Dan Raghinaru, Steven P Dunn, Robert L Schultze, David D Verdier and 10 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00006411 (Cornea Donor Study), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00006411 nacompletednot on this map

Cornea Donor Study: The Effect of Donor Age on Penetrating Keratoplasty for Endothelial Disease

TypeinterventionalSponsorNational Eye Institute (NEI)Ran2000 to 2014Enrolled1,090ConditionsCorneal Disease, Fuch's Dystrophy, Pseudophakic Corneal EdemaArmscorneas assigned by donor age group
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The impact of donor diabetes on corneal transplant immunity.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 3 countries.

Writing Committee for the Cornea Donor Study Research Group
Mark J MannisUniversity of California Davis, Sacramento, California. Electronic address: cds@jaeb.org.
Edward J HollandCincinnati Eye Institute, Department of Ophthalmology and Visual Sciences, Cincinnati, Ohio.
Robin L GalJaeb Center for Health Research, Tampa, Florida.
Mariya DontchevJaeb Center for Health Research, Tampa, Florida.
Craig KollmanJaeb Center for Health Research, Tampa, Florida.
Dan RaghinaruJaeb Center for Health Research, Tampa, Florida.
Steven P DunnMichigan Cornea Consultants, P.C., Southfield, Michigan.
Robert L SchultzeCornea Consultants of Albany, Albany, New York.
David D VerdierVerdier Eye Center, Grand Rapids, Michigan.
Jonathan H LassCase Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio.
Irving M RaberOphthalmic Partners of Pennsylvania, Bala Cynwyd, Pennsylvania.
Joel SugarUniversity of Illinois at Chicago, Chicago, Illinois.
Mark S GorovoyGorovoy Eye Specialists, Ft. Meyers, Florida.
Alan SugarW. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
R Doyle StultingEmory University (now at Woolfson Eye Institute), Atlanta, Georgia.
Monty M MontoyaSightLife, Seattle, Washington.
Jeffrey G PentaSan Diego Eye Bank, San Diego, California.
Beth Ann BenetzCase Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio.
Roy W BeckJaeb Center for Health Research, Tampa, Florida.
Jaeb Center for Health Research · USCase Western Reserve University · USCincinnati Eye Institute · USEmory University · USGerman United Services Trade Union · DESightLife · USUniversity of California, Davis · USUniversity of Illinois Chicago · USW.K. Kellogg Foundation · US

Funding

CORNEAL DONOR STUDYU10EY012358 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI BECK, ROY W. · 1999 to 2012
$8.5M
CORNEAL DONOR STUDY--SPECULAR MICROSCOPY ANCILLARY STUDYU10EY012728 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI LASS, JONATHAN H · 1999 to 2003
$359k
NEI NIH HHS EY12358NEI NIH HHS EY12728NEI NIH HHS U10 EY012358NEI NIH HHS U10 EY012728
6 · The paper itself

Abstract

objectiveTo determine whether the 10-year success rate of penetrating keratoplasty for corneal endothelial disorders is associated with donor age.

designMulticenter, prospective, double-masked clinical trial.

participantsA total of 1090 participants undergoing penetrating keratoplasty at 80 sites for Fuchs' dystrophy (62%), pseudophakic/aphakic corneal edema (34%), or another corneal endothelial disorder (4%) and followed for up to 12 years.

methodsForty-three eye banks provided corneas from donors aged 12 to 75 years, using a randomized approach to assign donor corneas to study participants without respect to recipient factors. Surgery and postoperative care were performed according to the surgeons' usual routines.

main outcome measuresGraft failure defined as a regraft or, in the absence of a regraft, a cloudy cornea that was sufficiently opaque to compromise vision for 3 consecutive months.

resultsIn the primary analysis, the 10-year success rate was 77% for 707 corneas from donors aged 12 to 65 years compared with 71% for 383 donors aged 66 to 75 years (difference, +6%; 95% confidence interval, -1 to +12; P = 0.11). When analyzed as a continuous variable, higher donor age was associated with lower graft success beyond the first 5 years (P<0.001). Exploring this association further, we observed that the 10-year success rate was relatively constant for donors aged 34 to 71 years (75%). The success rate was higher for 80 donors aged 12 to 33 years (96%) and lower for 130 donors aged 72 to 75 years (62%). The relative decrease in the success rate with donor ages 72 to 75 years was not observed until after year 6.

conclusionsAlthough the primary analysis did not show a significant difference in 10-year success rates comparing donor ages 12 to 65 years and 66 to 75 years, there was evidence of a donor age effect at the extremes of the age range. Because we observed a fairly constant 10-year success rate for donors aged 34 to 71 years, which account for approximately 75% of corneas in the United States available for transplant, the Cornea Donor Study results indicate that donor age is not an important factor in most penetrating keratoplasties for endothelial disease.

Indexed as

Keratoplasty, PenetratingTissue DonorsAdolescentAdultAgedAge FactorsAgingChildCorneal EdemaDouble-Blind MethodEye BanksFemaleFollow-Up StudiesFuchs' Endothelial DystrophyGraft SurvivalHumans

Identifiers

PMID24246825
PMCPMC3885822
OpenAlexW144357108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.